Medical Properties Trust, Inc. (MPT) — Fair Value Analysis

Base-case fair value (P50): $3.46 · Current price: $4.63 · Verdict: Overvalued

The Verdict on MPT

MEDICAL PROPERTIES TRUST REIT INC (MPT) currently trades at $4.63, significantly above its median fair value (P50) of $3.46 as determined by Monte Carlo simulations. This robust analysis, considering thousands of forward scenarios, indicates that MPT is Deeply Overvalued. Investors holding or considering MPT should note the substantial -25.3% downside implied by our models, suggesting a considerable price correction may be warranted to align with intrinsic value. The current market price diverges sharply from the simulated fair value, raising immediate concerns about the sustainability of MPT's valuation.

How MPT stacks up against peers

While MEDICAL PROPERTIES TRUST REIT INC's quality tier is currently unrated, the valuation gap remains stark when comparing the prevailing $4.63 to the Monte Carlo-derived $3.46. This "Deeply Overvalued" verdict is not based on direct peer comparisons, but rather on MPT's own fundamental projections under various simulated market conditions. The $4.63 suggests a market optimism that is not supported by the underlying probability distribution of its future cash flows. An unrated quality tier signals that our operational and financial health assessment against its sector is still under review, but the intrinsic valuation remains clear.

What this means for investors

The significant disconnect between MPT's $4.63 and its $3.46 fair value, underscored by a -25.3% gap, presents a critical alert for investors. Given the "Deeply Overvalued" status, a prudent approach would involve re-evaluating exposure to MPT at its current levels. Our Monte Carlo simulations provide a data-driven perspective on what MPT's value should be, rather than what the market says it is. For a complete understanding of the bear (P10) and bull (P90) case scenarios, and to track MPT's fair value as new fundamentals are released, sign up for a free FairCurve account today.

Frequently Asked Questions

Is MPT overvalued or undervalued right now?

Based on our Monte Carlo simulations, MPT is Deeply Overvalued, with its current price of $4.63 significantly higher than the median fair value (P50) of $3.46.

What is the bear case and bull case for MPT?

The full Monte Carlo distribution, including bear (P10) and bull (P90) targets, alongside the probability of upside, is exclusively available to users with a free FairCurve account. We do not provide specific dollar values here.

How does FairCurve calculate MPT's fair value?

FairCurve calculates MPT's fair value using advanced Monte Carlo simulations, running thousands of forward scenarios to determine a probability-weighted range of potential intrinsic values.

How can I track MPT's fair value as it changes?

You can add MPT to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuations whenever new earnings or fundamental data are released.